Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV's pipeline of antimalarial drugs
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Antimalarial drug availability
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Antimalarial drug toolkits
Artesunate injection dosage & administration
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Intellectual property rights (IPR)
Clinical centre partners by country
Our impact
Milestones
Malaria stories from the field
Antimalarial drugs for children
Gender equity
Global health security
Antimicrobial resistance to antimalarials
Malaria and COVID-19
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
5 species of
Plasmodium
parasites
Lifecycle of malaria parasite
Malaria facts & statistics
Malaria treatment
History of antimalarial drugs
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
The Global Health Priority Box
About the Global Health Priority Box
Supporting information
Request the Global Health Priority Box
Terms & conditions
Malaria
Libre
Malaria
Libre
open innovation platform
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News
News
Filter
All
R&D
Donors
General
Open source
Partner
Access & product management
All
R&D
Donors
General
Open source
Partner
Access & product management
15 found
Australia renews commitment to MMV and R&D for malaria
08 Jun 2018
MMV welcomes Philip Welkhoff, new Malaria Program Director, BMGF
14 Feb 2018
MMV welcomes continued Australian government support
24 Mar 2015
DFID pledges further support for MMV
22 Aug 2013
MMV receives funding to develop drugs to accelerate malaria eradication
22 Aug 2013
The Ian Bathurst Sponsorship Programme
07 Jul 2011
G-FINDER 2010: Good news with a twist in the tail for PDPs
18 Feb 2011
Germany to give €20M to neglected disease research
20 Oct 2010
MMV co-hosted meeting for donors in Barcelona - an unqualified success
24 Mar 2010
Memorial donation in memory of Prof. Dr. Michaela von Freyhold
02 Feb 2010
Outstanding review of MMV by Philanthropy Advisory Service
01 Dec 2009
World Bank Global Program Review (GPR) is published
15 Aug 2008
MMV and other PPPs encourage additional US Government support
11 Jan 2008
World Bank Reviews MMV’s Growth and Progress
18 Jul 2007
Dutch government pledges nearly €7 million to MMV
03 Nov 2006
